VitalTraq for Detection of CRS (Cytokine Release Syndrome)

Purpose of this Study

We are doing this study to evaluate the accuracy and utility of two remote vital sign monitoring devices, called TempTraq and VitalTraq, when used by blood cancer patients receiving chimeric antigen receptor (CAR) T-cell and bispecific T-cell engager (BiTE) therapies. In the future, these remote vital sign monitoring devices may help with earlier detection and intervention of treatment side effects, including cytokine release syndrome (CRS) and infections.

Who Can Participate?

Eligibility

Adults ages 18+ who:<ul>
<li>Have a hematologic malignancy</li>
<li>Are undergoing treatment with CAR-T or BiTE therapy</li>
<li>Own a smart phone that is compatible with the VitalTraq app and can connect to wi-fi</li>
<li>Can read and understand English</li></ul>
For more information about who can join this study, please contact one of the study team members below:
Chenyu Lin: <a href= "mailto: chenyu.lin@duke.edu">chenyu.lin@duke.edu</a> or 919-684-8964
Jennifer Tichon: <a href= "mailto: jennifer.tichon@duke.edu">jennifer.tichon@duke.edu</a> or 919-668-2556

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

If you choose to join the study, you will:<ul>
<li>Have information about your medical history and physical characteristics collected</li>
<li>Wear a TempTraq patch (a device that continuously monitors body temperature) on your skin under your arm for 15 days</li>
<li>Scan your face in VitalTraq (a mobile application that estimates blood pressure, heart rate, heart rate variability, and respiratory rate) 4-5 times per day for 15 days</li>
<li>Take your temperature with a digital thermometer 4-5 times per day for 15 days</li>
<li>Have your blood drawn for research</li>
<li>Complete a post-intervention survey</li></ul>

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Digital Multi-Vital Sign Monitoring for Early Detection of Cytokine Release Syndrome from Bispecific T-Cell Engagers and Chimeric Antigen Receptor Therapy

Principal Investigator

Chenyu
Lin

Protocol Number

PRO00115012

NCT ID

NCT06415656

Phase

N/A

Enrollment Status

Open to Enrollment